Side Effects and Adherence Associated With Doxycycline Use Following Medical Abortion

NCT ID: NCT01799252

Last Updated: 2014-02-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

582 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-11-30

Study Completion Date

2013-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The effectiveness of antibiotic treatment at reducing post-abortion infection is unclear. The experiences of women prescribed routine antibiotics after medical abortion is missing from the existing evidence. This study seeks to add to the literature evidence of the side effects associated with antibiotic treatment that women experience and their adherence to prescribed regimens.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Medical abortion (MA) consists of administering medication, typically a combination of mifepristone and misoprostol, to induce an abortion without any invasive procedures. Early first trimester MA is effective1, highly acceptable to women, and safe. The risk of infection following medical abortion is small, at less than 1%. In rare circumstances, pelvic infection with clostridia bacteria following medical abortion has resulted in death. Since 2000, when mifepristone was registered in the United States, 8 such deaths have been recorded in the US.

Following the publication of case reports of four clostridium-associated deaths after medical abortion in 2005, the reproductive health community reacted swiftly. Medical abortion protocols were altered in an effort to curb these drastic and rapidly fatal infections. Antibiotic treatment, typically a seven-day course of doxycycline, has become widespread in the United States.

The effectiveness of antibiotic treatment at reducing post-abortion infection is unclear. The experiences of women prescribed routine antibiotics after medical abortion is missing from the existing evidence. This study seeks to add to the literature evidence of the side effects associated with antibiotic treatment that women experience and their adherence to prescribed regimens.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Abortion

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Doxy

Women who are prescribed a seven-day regimen of doxycycline following medical abortion

No interventions assigned to this group

No Doxy

Women who are not prescribed antibiotics following medical abortion

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Women who are having MA at the study clinic and are willing to complete a self-administered, computer-based questionnaire 7-14 days after taking mifepristone
* Women who can read English or Spanish
* In the doxycycline arm: Women who have been prescribed doxycycline

Exclusion Criteria

* Women who were treated with antibiotics for a medical condition unrelated to their medical abortion between the initial visit and follow-up appointment
* Women who have previously enrolled in this study
Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Gynuity Health Projects

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Beverly Winikoff, MD, MPH

Role: PRINCIPAL_INVESTIGATOR

Gynuity Health Projects

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Feminist Women's Health Center

Atlanta, Georgia, United States

Site Status

Family Planning Associates

Chicago, Illinois, United States

Site Status

Planned Parenthood Mid and South Michigan

Ann Arbor, Michigan, United States

Site Status

Planned Parenthood MN, ND, SD

Saint Paul, Minnesota, United States

Site Status

Family Practice and Sidney Hillman Family Practice at the Institute for Family Health

New York, New York, United States

Site Status

NYU/Bellevue Hospital Center, Women's Health Center

New York, New York, United States

Site Status

Cedar River Clinic

Renton, Washington, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Frye LJ, Chong E, Winikoff B; NCT01799252 Trial Investigators. What happens when we routinely give doxycycline to medical abortion patients? Contraception. 2015 Jan;91(1):19-24. doi: 10.1016/j.contraception.2014.09.001. Epub 2014 Sep 15.

Reference Type DERIVED
PMID: 25444253 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

http://www.gynuity.org

Sponsor website

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

7000

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

A Study of Doxycycline to Treat Chlamydial Infection
NCT05840159 ACTIVE_NOT_RECRUITING PHASE4
Doxycycline for Elbow Tendinopathy
NCT04686799 ACTIVE_NOT_RECRUITING PHASE1
Tetracycline Treatment Tolerability Trial
NCT05219929 ENROLLING_BY_INVITATION PHASE2
Lipidome and Microbiome Profile of Acne
NCT02713607 ACTIVE_NOT_RECRUITING PHASE1/PHASE2
Ceftriaxone for Post-Treatment Lyme Disease
NCT06785402 RECRUITING PHASE1/PHASE2